• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Abstract #5067 The Nonclinical Toxicology Profile
Abstract #5067 The Nonclinical Toxicology Profile

... 15 nM), and it does not suppress JAK1 at clinically relevant concentra3ons. Addi3onal kinases targeted by pacri3nib and evaluated in a comprehensive kinome profile by Reac3on Biology Corp. include IRAK1 (IC50 = 13.6 nM) and c-fms (or CSF1R; IC50 = 39.5 nM). Pacri3nib is pharmacologically ac3ve in ...
Michael Barry Michael Barry - Irish Pharmaceutical Healthcare
Michael Barry Michael Barry - Irish Pharmaceutical Healthcare

... 2. Value for money afforded by the relevant listed items 3. Equivalent relevant prices in other Member States ( EU 28 ). 4. The relevant prices of therapeutically similar listed items e.g. simvastatin for atorvastatin 5. Resources available to the Executive 6. The terms of any agreements in place wi ...
File
File

... • From the proteome, enzymes involved in parasitic metabolism have been identified as potential targets for inhibition. • These enzymes may be screened against a bioinformatics database of chemicals to identify potential enzyme inhibitors. – Once a promising compound is identified, it may be chemica ...
Antidepressant Drugs
Antidepressant Drugs

... Tricyclics are related to the phenothiazines and have similar adverse effects to them, for the most part anticholinergic, but also: ...
Cutaneous Side Effects of New Antitumor Drugs
Cutaneous Side Effects of New Antitumor Drugs

... (Table 1). Topical and systemic glucocorticosteriods can be used, while keeping in mind that dose reduction or discontinuation of the suspected trigger substance may be necessary. For pruritus, possible triggers should be investigated primarily by analyzing the medical history and clinical examinati ...
Selective phosphodiesterase inhibitors for the treatment
Selective phosphodiesterase inhibitors for the treatment

... High concentrations of theophylline suppress reactive oxygen metabolite production by neutrophils and eosinophils but lower concentrations enhance this response [74,75]. At high concentrations, the survival time of eosinophils in culture is reduced [76], apparently through the induction of apoptosis ...
COX-2
COX-2

... ANTI-COAGULATION RX COX-2 INHIBITORS ...
2.5 Other Antihypertensive Drugs - Doncaster and Bassetlaw Hospitals
2.5 Other Antihypertensive Drugs - Doncaster and Bassetlaw Hospitals

... Methyldopa is not recommended as a first line agent due to adverse effects. It is, however, a safe option for use in pregnancy. Doxazosin is used for treatment of hypertension where other drugs have failed to control blood pressure, or in patients with contraindications to other antihypertensive dr ...
EGFR TYROSINE KINASE TARGETED COMPOUNDS: IN VITRO
EGFR TYROSINE KINASE TARGETED COMPOUNDS: IN VITRO

... Compounds 1-5 were evaluated for their antitumor activity in accordance with the current protocol of the National Cancer Institute (NCI), USA. They displayed lethal activity against non-small cell lung cancer (NCI-H522), colon cancer (HCT-116, HCT15 and HT29) and breast cancer (MDA-MB468 and MDA-MB- ...
DPP-4 inhibitors
DPP-4 inhibitors

... vildagliptin studies with available side effect data reported a small increased risk of • nasopharyngitis (relative risk [RR] 1.2, 95% CI 1.0-1.4) • urinary tract infection (RR 1.5, 95% CI 1.02.2), and • headache (RR 1.4, 95% CI 1.1-1.7) [7 ...
CHF
CHF

... •don’t decrease the vasodilators •the beta-blocker should probably also be continued (perhaps after the first few hours which are needed to stabilize the patient). •consider tailored therapy if vasodilators appear to be at maximum-tolerated dose. ...
Structure-based design of enzyme inhibitors and receptor ligands
Structure-based design of enzyme inhibitors and receptor ligands

... with a natural product which was isolated from the marine sponge Theonella. Cyclotheonamide (12) [22,24] is a cyclic peptide with a Pro-Arg sequence and a β-diketone moiety (Figure 3), which readily forms a hemiketal with the hydroxyl group of the catalytically active Ser-195 of thrombin [62]. A fir ...
Novel orally bioavailable BRAF inhibitors for the treatment of Opportunity
Novel orally bioavailable BRAF inhibitors for the treatment of Opportunity

... onset of squamous cell carcinoma, which is observed as a sideeffect with vemurafenib, the current treatment (Su et al. NEJM ...
Heart Failure
Heart Failure

... •Vasoconstriction by (-) enantiomer is countered by (+) enatiomer and 2 agonist activity- ultimate result is a decrease in PVR and mild decrease in systemic blood pressure ...
Antidepressants in Hepatic Failure Antidepressants in Renal Failure
Antidepressants in Hepatic Failure Antidepressants in Renal Failure

... Fluoxetine - need significant dosage decrease (at least 50%), even in compensated cirrhosis. Is also potent inhibitor of CYP2D6. ...
An Innovative Approach to New Antimicrobial Drugs SUMMARY
An Innovative Approach to New Antimicrobial Drugs SUMMARY

... 1.   Measurement   of   various   kinetic  isotope   effects   (KIEs)   for   the   reactions   catalysed   by   human   and   E.   coli   DHFRs.   This   will   require   the   production   of   DHFR   substrates   (NADPH   and   dihydrofolate ...
Lecture 3 - Renin Angiotensin Pathway
Lecture 3 - Renin Angiotensin Pathway

... related peptidase enzymes – fits binding model. • Given that Proline is the C-terminal amino acid in SQ20881, succinyl-L-proline was synthesised and tested. ...
1 -blocker
1 -blocker

... How would this affect dosing? Less effective in blacks unless combined with thiazide diuretics ...
Sympathetic NS
Sympathetic NS

... Hypertension, angina, arrhythmias, tremor, β, non-selective, LA-action, no ISA; A very useful ...
Case Report - Thalidomide and hyperkalemia
Case Report - Thalidomide and hyperkalemia

... proliferation In some tumor types, such as RCC and certain lymphomas, mTOR as key role in tumor cell proliferation and angiogenesis Temsirolimus and everolimus are approved as monotherapy in advanced RCC ...
Drug Interactions
Drug Interactions

... Accounts for 30% of P450 activity in liver and 70% in gut Performs the bulk of oxidative metabolism of drugs Phase I metabolism of endogenous and exogenous compounds including hydroxylation, demethylation and ...
Lecture 1- NSAIDs
Lecture 1- NSAIDs

... 11 hours ...
CHF Drugs
CHF Drugs

... - angioneurotic edema (class specific to if you get it on one ACE inhibitor, you’ll get it with all. SE profile occurs in 20 % of all patients. Considerations: Class III & IV HF  hypotension if not monitored properly, which will decrease renal function and injure kidneys more. Over time, you may ge ...
Serotonin-Norepinephrine Reuptake Inhibitors
Serotonin-Norepinephrine Reuptake Inhibitors

... Serotonin-norepinephrine-dopamine-reuptakeinhibitors (SNDRI) are a class of psychoactive antidepressants. They act upon neurotransmitters in the brain, namely, serotonin, norepinephrine and dopamine. These three biogenic monoamines are associated with depression and increasing the availability in th ...
Popular Links - UNC School of Medicine
Popular Links - UNC School of Medicine

... • Presence of medical illness may cause ...
< 1 ... 15 16 17 18 19 20 21 22 23 ... 28 >

Metalloprotease inhibitor

Metalloprotease inhibitors are cellular inhibitors of the matrix metalloprotease (or metalloproteinase) family of proteins (MMP).Several other proteins have similar inhibitory effects, however none as effective (netrins, procollagen C-terminal proteinase enhancer (PCPE), reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and tissue factor pathway inhibitor (TFPI-2)). They might have other biological activities which have yet been fully characterised.There are three classes of commonly used inhibitors for metalloproteinases. In vitro, EDTA, 1,10-phenanthroline and other chelating compounds lower the concentration of metal to the point where the metal is removed from the enzyme active site. Classical lock and key inhibitors such as phosphoramidon and bestatin bind tightly by approximating the transition state of the hydrolysis of the peptide, preventing it from acting on other substrates. Protein inhibitors such as α2-macroglobulin are known to work with metalloproteinases.↑
  • studyres.com © 2026
  • DMCA
  • Privacy
  • Terms
  • Report